Skip to main content
Log in

Clinical Spectrum of Primary Hyperparathyroidism

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cope O. The story of hyperparathyroidism at the massachusetts general hospital. N Engl J Med 1966;21(1): 174-1182.

    Google Scholar 

  2. Albright F, Aub JC, Bauer W. Hyperparathyroidism common and polymorphic condition as illustrated by seventeen proved cases from one clinic. J Am Med Assoc 1934;102:1276-1287.

    Google Scholar 

  3. Keating FR Jr, Cook EN. Recognition of primary hyperparathyroidism: analysis of 24 cases. J Ain Med Assoc 1945;129:994-1002.

    Google Scholar 

  4. Heath H III, Hodgson SF, Kennedy M. Primary hyperparathyroidism: incidence, morbidity and potential economic impact in a community. N Engl J Med 1980;302:189-193.

    Google Scholar 

  5. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet 1980;1:1317-1320.

    Google Scholar 

  6. Stenstrom G, Heedman P. Clinical findings in patients with hypercalcemia: a final investigation based on biochemical screening. Acta Med Scand 1974;195:473-477.

    Google Scholar 

  7. Melton LJ III. Epidemiology of primary hyperparathyroidism. J Bone Mineral Res 1991;6(Suppl 2):S25-S30.

    Google Scholar 

  8. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ III. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997;126:433-440.

    Google Scholar 

  9. Cohen J, Gierlowski TC, Schneider AB. A prospective study of hyperparathyroidism in individuals exposed to radiation in childhood. JAMA 1990;264:581-584.

    Google Scholar 

  10. Bondeson AG, Bondeson L, Thompson NW. Hyperparathyroidism after treatment with radioactive iodine: not only a coincidence?. Surgery 1989;106:1025-1027.

    Google Scholar 

  11. Bilezikian JP, Silverberg SJ, Shane E, Parisien M, Dempster DW. Characterization and evaluation of asymptomatic primary hyperparathyroidism. J Bone Mineral Res 1991;6(Suppl I):585-589.

    Google Scholar 

  12. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. The natural history of treated and untreated asymptomatic primary hyperparathyroidism: a ten year prospective study. N Engl J Med 1999;341:1249-1255.

    Google Scholar 

  13. Silverberg SJ, Shane E, DeLaCruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Mineral Res 1989;4:283-291.

    Google Scholar 

  14. Turken SA, Cafferty M, Silverberg SJ, et al. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 1989;87:553-557.

    Google Scholar 

  15. Parisien MV, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW. The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 1990;70:930-938.

    Google Scholar 

  16. M, Cosman F, Mellish RWE, Schnitzer M, Nieves J, Silverberg SJ, Shane E, Kimmel, Recker R, Bilezikian JP, Lindsay R, Dempster DW. Bone structure in postmenopausal hyperparathyroid, osteoporotic and normal women. J Bone Min Res 1995;10:1393-1399.

    Google Scholar 

  17. Dempster DW, Parisien M, Silverberg SJ, Liang X-G, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 1999;84:1562-1566.

    Google Scholar 

  18. Silverberg SJ, Locker FG, Bilezikian JP. Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 1996;81:4007-4012.

    Google Scholar 

  19. Miller PD, Bonnick SL. Clinical applications of bone densitometry. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th edition (Favus MJ), Philadelphia: Lippincott Williams & Co, 1999;152-159.

    Google Scholar 

  20. Dauphine RT, Riggs BL, Scholz DA. Back pain and vertebral crush fractures: an unrecognized mode of presentation for primary hyperparathyroidism. Ann Intern Med 1975;83:365-367.

    Google Scholar 

  21. RJ, Rao DS, Ellis B, Kleerekoper M, Parfitt AM. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 1988;109:959-962.

    Google Scholar 

  22. LJ III, Atkinson EJ, O'Fallon WM, Heath H III. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 1992;152:2269-2273.

    Google Scholar 

  23. Kleerekoper M, Peterson E, Nelson D, et al. Identification of women at risk for developing postmenopausal osteoporosis with vertebral compression fractures: role of history and single photon absorptiometry. Bone Mineral 1989;7:171-186.

    Google Scholar 

  24. Johnson BE, Lucasey B, Robinson RG, Lukert BP. Contributing diagnoses in osteoporosis. Arch Intern Med 1989;149:1069-1072.

    Google Scholar 

  25. Khosla S, Melton LJ III, Wermers RA, Crowson CS, O'Fallon WM, Riggs BL. Primary hyperparathyroidism and the risk of fracture: a population based study. J Bone Min Res 1999;14:1700-1707.

    Google Scholar 

  26. Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D, Clemens TL, Bilezikian JP. Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 1990;89:327-334.

    Google Scholar 

  27. Albright F, Reifenstein EC. The parathyroid glands and metabolic bone disease. Baltimore: Williams & Wilkins, 1948.

    Google Scholar 

  28. Fitzpatrick LA, Bilezikian JP. Acute primary hyperparathyroidism. Am J Med 1987;82:275-282.

    Google Scholar 

  29. Locker FG, Silverberg SJ, Bilezikian JP. Optimal calcium intake in primary hyperparathyroidism. Am J Med 1997;102:543-550.

    Google Scholar 

  30. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP. Vitamin D Deficiency in primary hyperparathyroidism. Am J Med 1999;107:561-567.

    Google Scholar 

  31. Deftos LJ. Markers of bone turnover in primary hyperparathyroidism. In: Bilezikian JP (ed.): The Parathyroids: Basic and Clinical Concepts. New York: Raven Press, 1994;485-492.

    Google Scholar 

  32. Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezkian JP. Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism. J Clin Endocrinol Metab 1992;74:481-486.

    Google Scholar 

  33. LE, Bilezikian JP, Heath DA, Aurbach GD. Primary hyperparathyroidism: Clinical and biochemical features. Medicine 1974;53:127-146.

    Google Scholar 

  34. Parisien M, Mellish RWE, Silverberg SJ, et al. Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Mineral Res 1992;7:913-920.

    Google Scholar 

  35. Deaconson TF, Wilson SD, Lemann J. The effect of parathyroidectomy on the recurrence of nephrolithiasis. Surgery 215:241-251.

  36. Palmer M, Adami H-O, Bergstrom R, Akerstroon G, Ljunghall, S. Mortality after surgery for primary hyperparathyroidism: a followup of 441 patients operated on from 1956 to 1979. Surgery 1987; 102:1-7

    Google Scholar 

  37. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM, Melton LJ III. Survival after the diagnosis of hyperparathyroidism: a population based study. Am J Med 1998;104:115-122.

    Google Scholar 

  38. Harinarayan DV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol 1995;43:351-358.

    Google Scholar 

  39. Luong KVQ, Nguyen LTH. Co-existing hyperthyroidism and hyperparathyroidism with vitamin D deficient osteomalacia in a Vietnamese immigrant. Endocr Practice 1996;2:250-254.

    Google Scholar 

  40. XW, Xing XP, Liu SQ, Zhan ZW. The diagnosis of primary hyperparathyroidism-analysis of 134 cases. Acta Acad Med Sinicae 1994;16:13.

    Google Scholar 

  41. Bilezikian JP, Meng X, Shi Y, Silverberg SJ. Primary hyperparathyroidism in women: New York and Beijing (A Tale of Two Cities). Int'l J Fertil and Women's Health 2000;45:158-165 (in press), 2000

    Google Scholar 

  42. Patron P, Gardin J-P, Paillard M. Renal mass and reserve of vitamin D. Determinants in primary hyperparathyroidism. Kidney Int 1987;31:1174-1180.

    Google Scholar 

  43. Lumb GA, Stanbury SW. Parathyroid function in vitamin D deficiency in primary hyperparathyroidism. Am J Med 1974;54:833-839.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bilezikian, J.P., Silverberg, S.J. Clinical Spectrum of Primary Hyperparathyroidism. Rev Endocr Metab Disord 1, 237–245 (2000). https://doi.org/10.1023/A:1026508829397

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026508829397

Navigation